Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • demis001
    Member
    • Apr 2009
    • 10

    MISO compare two samples with replicate; RNA-SEQ

    How can I compare two samples of RNA-SEQ with biological replicate using MISO?

    Assuming, I have 10 biological replicates for control and 10 biological replicate for knockdown samples. How can modify the following line to read 10 MISO run under the control directory and 10 MISO run under knockdown directory and compare the two samples with biological replicate?

    python run_miso.py --compare-samples control/ knockdown/ comparisons/

    Thanks
    DD
  • bioliyezhang
    Member
    • Mar 2011
    • 19

    #2
    Originally posted by demis001 View Post
    How can I compare two samples of RNA-SEQ with biological replicate using MISO?

    Assuming, I have 10 biological replicates for control and 10 biological replicate for knockdown samples. How can modify the following line to read 10 MISO run under the control directory and 10 MISO run under knockdown directory and compare the two samples with biological replicate?

    python run_miso.py --compare-samples control/ knockdown/ comparisons/

    Thanks
    DD
    Hi, demis:

    I wonder whether you have figured out how to do that? I have the exactly the same question as you. Can you give me some idea if you know how to do it?
    Thanks a lot.

    Comment

    • Simon Anders
      Senior Member
      • Feb 2010
      • 995

      #3
      Has MISO been updated to now be able to handle biological replicates?

      The method presented in the Nature paper could not, which is a very severe limitation and and was one of reasons why we saw a need for a new method and developed DEXSeq (Anders, Reyes, Huber; Genome Res, 2012).

      Comment

      • bioliyezhang
        Member
        • Mar 2011
        • 19

        #4
        Originally posted by Simon Anders View Post
        Has MISO been updated to now be able to handle biological replicates?

        The method presented in the Nature paper could not, which is a very severe limitation and and was one of reasons why we saw a need for a new method and developed DEXSeq (Anders, Reyes, Huber; Genome Res, 2012).
        Hi, Simon:

        thanks. So far, I think the current version of MISO still does not handle biological replicates. I will try the DEXSeq.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        44 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Working...